112200 ⎘
Uses of viruses as vector for the expression of a heterologous nucleic acid
Sub-classes:METHODS FOR MANUFACTURING ADOPTIVE CELL THERAPIES
#2Phagemid Vector
#3NERVE REGENERATION
#4TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN
#5METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#6Phagemid vector
#7In vivo production of small interfering RNAs that mediate gene silencing
#8Measles virus encoding a tumor antigen
#9Optogenetic control of endothelial cells
#10TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN
#11RNA interference suppression of neurodegenerative diseases and methods of use
#12METHOD OF ENHANCING VIRAL-MEDIATED GENE DELIVERY
#13Lipid hydrolysis therapy for atherosclerosis and related diseases
#14Methods for manufacturing adoptive cell therapies
#15In vivo production of small interfering RNAs that mediate gene silencing
#16MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
#17Compositions and methods for increasing bone mineralization
#18siRNA-mediated gene silencing
#19Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#20Vaccine for treatment of tautopathy
#21Optogenetic control of endothelial cells
#22METHODS AND COMPOSITIONS TO MODULATE ANTIVIRAL AND IMMUNE ACTIVITY RESPONSES
#23MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
#24RNA interference suppression of neurodegenerative diseases and methods of use thereof
#25In vivo production of small interfering RNAs that mediate gene silencing
#26Methods for therapy of neurodegenerative disease of the brain
#27Vaccine for treatment of tautopathy
#28Compositions and methods for increasing bone mineralization
#29Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity
#30SiRNA-mediated gene silencing
#31Antagonists against TNFR1 and methods of use therefor
#32Methods and compositions to modulate antiviral and immune activity responses
#33Tumor suppressor designated TS10Q23.3
#34Anticalins
#35Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
#36GENE REPAIR INVOLVING IN VIVO EXCISION OF TARGETING DNA
#37INTERFERON-LIKE PROTEINS AND USES THEREOF
#38FOAMYVIRUS VECTORS AND METHODS OF USE
#39VECTOR FOR TREATING ALZHEIMER'S DISEASE
#40Akt Nucleic Acids, Polypeptides, and Uses Thereof
#41Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof
#42System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
#43CRUSTACEAN EXPRESSION VECTOR
#44Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
#45SiRNA-mediated gene silencing
#46LIGAND THAT HAS BINDING SPECIFICITY FOR IL-4 AND/OR IL-13
#47Compositions and Methods for Treatment of Uncontrolled Cell Growth
#48RNA interference suppression of neurodegenerative diseases and methods of use thereof
#49In vivo production of small interfering RNAs that mediate gene silencing
#50Apoptosis modulator Bcl-B and methods for making and using same
#51Secreted Epithelial Stromal-1 Molecules and Uses Thereof
#52Compositions and Methods for Increasing Bone Mineralization
#53RICIN-LIKE TOXIN VARIANTS FOR TREATMENT OF CANCER, VIRAL OR PARASITIC INFECTIONS
#54Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
#55RNA interference suppresion of neurodegenerative diseases and methods of use thereof
#56Vectors Containing the Max Gene
#57OX40R Binding Agents
#58METHODS FOR TREATING BLOOD COAGULATION DISORDERS
#59Anticalins
#60Feline granulocyte macrophage colony stimulating factor proteins
#61Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains
#62Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases
#63Vivo production of small interfering RNAs that mediate gene silencing
#64In vivo production of small interfering RNAS that mediate gene silencing
#65INFLUENZA THERAPEUTIC
#66USE OF RAPAMYCIN TO INHIBIT IMMUNE RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS
#67siRNA-MEDIATED GENE SILENCING WITH VIRAL VECTORS
#68TUMOR SUPPRESSOR DESIGNATED TS10Q23.3
#69METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#70Compositions and methods for increasing bone mineralization
#7126199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
#72siRNA-mediated gene silencing with viral vectors
#73AKT nucleic acids, polypeptides, and uses thereof
#74OX40R binding agents
#75HOLIN-ENHANCED VACCINES AND REAGENTS, AND METHODS OF USE THEREOF
#76Polynucleotide
#77Regulation of angiogenesis with zinc finger proteins
#78Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#7919.5 polypeptide antibodies useful for diagnosing or treating psoriasis
#80NK Cell Receptor Conjugates for Treating Malignancies
#81METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#82MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
#83Lynx polypeptides
#84Antibodies which bind to epitopes of glycoprotein VI
#85TNF RECEPTOR-LIKE MOLECULES AND USES THEREOF
#86Compositions and methods for WT1 specific immunotherapy
#87Apoptosis modulator BCL-B and methods for making and using same
#88Preparing a homogenous population of stem cells committed to differentiated to a specific cell type
#89Modulators of TNF receptor associated factor (TRAF), their preparation and use
#90Development of a simple animal model for infection by viruses and other obligate intracellular parasites
#91Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
#92METHOD FOR TREATING DIABETES MELLITUS, OBESITY, CHRONIC FATIGUE, AGING, AND OTHER MEDICAL CONDITIONS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MESSENGER RIBONUCLEIC ACID MOLECULES INTO CELLS
#93Mutant Forms of Fas Ligand and Uses Thereof
#94BMX/ETK TYROSINE KINASE GENE THERAPY MATERIALS AND METHODS
#95Methods for detecting the presence of mutant mammalian presenilin protein
#96FLEA HEAD, NERVE CORD, HINDGUT AND MALPIGHIAN TUBULE NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
#97Modulators of antiestrogen pharmacology
#98Methods, products and uses involving platelets and/or the vasculature
#99Influenza Therapeutic
#100CANINE AND FELINE IMMUNOREGULATORY PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF
#101Influenza Therapeutic
#102IREN PROTEIN, ITS PREPARATION AND USE
#103nucleic acid molecules
#104Gene repair involving in vivo excision of targeting DNA
#105FLEA ALLANTOINASE PROTEINS AND USES THEREOF
#106Tick octopamine receptor nucleic acid molecules
#107Biotin-binding receptor molecules
#108Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
#109Antibody specific for mutant presenilin 2 and method of use thereof
#110Method of enhancing a targeted immune response against tumors
#111Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
#112DROSOPHILA G PROTEIN COUPLED RECEPTORS, NUCLEIC ACIDS, AND MEHTODS RELATED TO THE SAME
#113Compositions and methods for increasing bone mineralization
#114Ligand that has binding specificity for IL-4 and/or IL-13
#115Ligand that has binding specificity for IL-4 and/or lL-13
#116In vivo production of small interfering RNAs that mediate gene silencing
#117Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
#118Compositions and methods for increasing bone mineralization
#119Monocyte locomotion inhibitory factor
#120Anti-angiogenic and anti-tumor properties of matin and other laminin domains
#121Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
#122Recombinant glycoproteins related to feline thyrotropin
#123USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS
#124Methods and compositions for inhibiting the function of polynucleotide sequences
#125INHIBITION OF EXPRESSION OF A TARGET GENE
#126Antibody directed to protein involved in maintaining differentiation of smooth muscle cells
#127Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus
#128Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
#129Flea peritrophin nucleic acid molecules
#130Screening methods for compounds useful in the regulation of body weight
#131Ligands That Enhance Endogenous Compounds
#132Combinatorial Methods For Inducing Cancer Cell Death
#133Crustacean expression vector
#134Methods of treatment using antibodies to follistatin-3
#135Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
#136Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
#137METHODS OF USING AN EQUINE FC EPSILON RECEPTOR ALPHA CHAIN PROTEIN
#138Methods and compositions for inhibiting the function of polynucleotide sequences
#139Methods and compositions for inhibiting the function of polynucleotide sequences
#140Methods and compositions for inhibiting the function of polynucleotide sequences
#141Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use
#142Geranylgeranyl pyrophosphate synthases
#143Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof
#144Geranylgeranyl pyrophosphate synthases
#145Canine IL-5 proteins and fragments thereof
#146Geranylgeranyl pyrophosphate synthases
#147VGLUT-specific dsRNA compounds
#148Ligand that has binding specificity for IL-4 and/or IL-13
#149Modified CEA nucleic acid and expression vectors
#150Regulation of angiogenesis with zinc finger proteins
#151Agents which bind to epitopes of glycoprotein VI
#15226199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
#153Secreted epithelial colon stromal-1 molecules and uses thereof
#154Treatment for heart disease
#155Tumor suppressor designated TS10Q23.3
#156Tumor suppressor designated TS10q23.3
#157Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
#158Methods for therapy of neurodegenerative disease of the brain
#159Method for treating ischemic diseases
#160Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#161Peptides against autoantibodies causing intolerance to cold and use thereof
#162Antibody to TNF receptor-like molecules
#163OX40R binding agents
#164Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
#165Transforming growth factor-beta-related molecules and uses thereof
#166Novel matrix metalloproteinases
#167Human voltage gated sodium channel β1A subunit and methods of use
#168Methods and compositions for introducing biopolymers into cells
#169Ligand
#170Transgenic Mice Containing Kir3.3 Potassium Channel Gene Disruptions
#171Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
#172In vivo gene therapy of parkinson's disease
#173Antagonists il-15
#174Antibodies specific for sclerostin
#175Drug for auditory dysfunction
#176Feline interferon-alpha proteins
#177Canine B7-1 nucleic acid molecules
#178Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
#179Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
#180Viral agents
#181Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-α
#182Ribozyme therapy for the treatment of proliferative skin and eye diseases
#183Method of inducing neuronal production in the brain and spinal cord
#184Method of inducing neuronal production in the caudate nucleus and putamen
#185Nk cell receptor conjugates for treating malignancies
#186Influenza therapeutic
#187Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
#188Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia
#189Methods and compositions for elucidating protein expression profiles in cells
#190Method of treating a cancer
#191proteins
#192Inhibition of cell division based use of analogs of neuropeptide y
#193Methods and compositions for inhibiting the function of polynucleotide sequences
#194Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
#195Human homologues of fused gene
#196Anticalins
#197ADP-ribosylating bacterial toxins
#198Expression of proteins in cord blood-derived endothelial cells
#199Method of treating reproductive system cancer by administering follistatin-3
#200Interferon-like proteins and uses thereof
#201TNFr/OPG-like molecules and uses thereof
#202Bone mineralization proteins, DNA, vectors, expression systems
#203NERVE REGENERATION
#204Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
#205siRNA-Mediated gene silencing with viral vectors
#206In vivo production of small interfering RNAS that mediate gene silencing
#207Cell cycle genes in plants
#208Methods for therapeutic vaccination
#209Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
#210Flea octopamine receptor nucleic acid molecules, proteins and uses thereof
#211NTR3, a novel member of the TNF- receptor supergene family
#212Regulation of angiogenesis with zinc finger proteins
#213Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
#214Antibodies for diagnosing psoriasis
#215Nucleic acid silencing of Huntington's Disease gene
#216Novel genes encoding protein kinase/protein phosphatase
#217MEKK1-interacting FHA protein 1 (MIF1)
#218Methods and compositions for inhibiting the function of polynucleotide sequences
#219Flea head, nerve cord, hindgut and malpighian tubule proteins
#220Chordin-like molecules and uses thereof
#221Interferon-like molecules and uses thereof
#222Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
#223Chordin-like molecules and uses thereof
#224Chordin-like molecules and uses thereof
#225Antibody specific for mutant presenilin 1
#226Chordin-like molecules and uses thereof
#227Antibodies specific for CD44v6
#228Fibroblast growth factor-like molecules and uses thereof
#229Tumor treating composition and methods
#230Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#231Cytoplasmic inhibition of gene expression
#232G-coupled receptor showing selective affinity for ATP
#233Flea allantoinase nucleic acid molecules, proteins and uses thereof
#234Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
#235Method of enhancing a targeted immune response against tumors
#236Polynucleotide
#237Equine Fc epsilon receptor alpha protein
#238Genes associated with the maintenance of differentiation of smooth muscle cells
#239Geranylgeranyl pyrophosphate synthases
#240G-coupled receptor showing selective affinity for ATP
#241Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
#242Tumor suppressor designated TS10q23.3
#243Human Akt3 nucleic acid and uses thereof
#244Immunoadhesin comprising a glycoprotein VI domain
#245Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof
#246MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
#247Animal model for the analysis of tumor metastasis
#248Novel human thrombospondin-like proteins and polynucleotides encoding the same
#249Methods for therapy of neurodegenerative disease of the brain
#250Nucleic encoding interleukin-1 receptor antagonist-like proteins and uses thereof
#251Pseudomonas syringae harpins, hopptop and hoppmahpto, and their uses
#252Geranylgeranyl pyrophosphate synthases
#253Gene therapy vectors having reduced immunogenicity
#254MHC class II epitopes of 5T4 antigen
#255Glucose dehydrogenase fusion proteins and their use in expression systems
#256Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells
#257Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. Use of said regulator as a therapeutic or diagnostic agent
#258Tissue-specific and pathogen-specific ribozymes
#259siRNA-mediated gene silencing with viral vectors
#260Flea allantoinase proteins and uses thereof
#261Method of detecting disease conditions in infected with animal virus
#262DNA immunization against infection
#263Method of protein production using mitochondrial translation system
#264Polynucleotides encoding immunoadhesins comprising a glycoprotein VI domain
#265Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes
#266Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
#267Methods and compositions for inhibiting the function of polynucleotide sequences
#268Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
#269Methods and compositions for inhibiting the function of polynucleotide sequences
#270Method of inhibiting prion protein
#271Transgenic avians with an ovomucoid gene expression control region linked to a nucleotide sequence encoding a heterologous polypeptide
#272Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
#273Methods and compositions for inhibiting the function of polynucleotide sequences
#274RNA interference suppresion of neurodegenerative diseases and methods of use thereof
#275Pax-encoding vector and use thereof
#276Specific inhibition of allorejection
#277Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
#278Compositions and methods for delivery of short interfering RNA and short hairpin RNA
#279Methods and compositions for inhibiting the function of polynucleotide sequences
#280Neuroprotective peptides and uses thereof
#281Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
#282Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
#283Vaccine to protect animals against leishmania